AtaiBeckley

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch AtaiBeckley and buy or sell other stocks, ETFs, and their options commission-free!

About ATAI

Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. 

CEO
Srinivas G. Rao
CEOSrinivas G. Rao
Employees
54
Employees54
Headquarters
Amstelveen, Noord-Holland
HeadquartersAmstelveen, Noord-Holland
Founded
2020
Founded2020
Employees
54
Employees54

ATAI Key Statistics

Market cap
2.67B
Market cap2.67B
Price-Earnings ratio
-5.09
Price-Earnings ratio-5.09
Dividend yield
—
Dividend yield—
Average volume
3.73M
Average volume3.73M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$6.75
52 Week high$6.75
52 Week low
$1.15
52 Week low$1.15

Stock Snapshot

With a market cap of 2.67B, AtaiBeckley(ATAI) trades at $7.35. The stock has a price-to-earnings ratio of -5.09.

During the trading day, AtaiBeckley(ATAI) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 3.73M.

Over the past 52 weeks, AtaiBeckley(ATAI) stock has traded between a high of $6.75 and a low of $1.15.

Over the past 52 weeks, AtaiBeckley(ATAI) stock has traded between a high of $6.75 and a low of $1.15.

People also own

Based on the portfolios of people who own ATAI. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.